LIVE QUOTE
Henry Schein, Inc. HSIC
Healthcare · Medical - Distribution · NASDAQ
$72.72
Market Cap$8.0B
P/E Ratio14.0
Beta0.82
Employees25,000

Investment Thesis

and warrant an increased position.

Competitive Moat

characterized primarily by economies of scale and switching costs. As one of the largest health care distributors, its extensive logistics network allows for cost advantages and efficient distribution, which smaller players cannot replicate easily. Moreover, the integration of technology and practice management solutions creates switching costs for customers, as transitioning to a competitor would require substantial investment in new systems and retraining. The durability of this moat is strong over the next 5-10 years, although emerging competitors utilizing innovative delivery models and digital platforms pose potential threats.

Growth Engine

Future revenue growth for HSIC will primarily stem from expanding its total addressable market (TAM) in healthcare services and products, driven by demographic trends and increasing demand for dental and medical supplies. The company is well-positioned to capitalize on organic growth through its technology and value-added services segment, which enhances customer retention and drives additional sales. Geographic expansion, particularly in underserved markets, will provide a significant opportunity for market share gains. While HSIC has historically made acquisitions to bolster its portfolio, the focus on organic growth strategies is expected to yield higher margins and sustainable long-term value.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research HSIC
Robinhood
$0 commission trades
Trade HSIC
Webull
Extended-hours, options, charts
Trade HSIC
TradingView
Advanced charts & screeners
Chart HSIC
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-05-27, Henry Schein, Inc. (HSIC) has a P/E ratio of N/A, which may indicate that it is not currently profitable or that earnings are not available for comparison. Investors should consider the company's growth prospects and market conditions in the healthcare distribution sector before making a decision.
Henry Schein, Inc. does not currently pay a dividend, as indicated by the absence of a dividend yield in the provided data.
Henry Schein, Inc. operates in the Healthcare sector, specifically within the Medical - Distribution industry.
The market cap for Henry Schein, Inc. is not provided, but given the nature of the company and its operations, it is likely to fall into the mid-cap category, which ranges from $2 billion to $10 billion.
Henry Schein, Inc. competes with companies such as McKesson Corporation and Cardinal Health, both of which are also involved in the healthcare distribution industry.
FAQ generated 2026-05-27

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms